Compare Johnson & Johnson (JNJ) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Modine Manufacturing Company — how do they compare? Johnson & Johnson trades at $260.76 (market cap $618.09B), while Modine Manufacturing Company trades at $182.03 (market cap $9.66B). The key difference: Johnson & Johnson is far larger — about 64× Modine Manufacturing Company's market cap, and Johnson & Johnson pays a 2.09% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Modine Manufacturing Company for 33 Days on average.
| JNJ | MOD | |
|---|---|---|
Market Cap | $618.09B | $9.66B |
Volume | 6,050,983 | 1,331,946 |
Sector | Health | Industrials |
52-Week High | $278.43 | $283.95 |
52-Week Low | $186.00 | $110.73 |
Typical Hold Time | 129 Days | 33 Days |
Enterprise Value | $646.37B | $10.09B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
Modine Manufacturing (MOD) trades at $182.00, down 3.93% on the day, amid a bearish technical signal and recent volatility following the completion of its Performance Technologies spin-off and merger with Gentherm. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $1.53 surpassing the $1.30 expectation. Analyst sentiment remains strongly positive with a consensus price target of $331.25, though technical indicators show selling pressure with key support at $177 and resistance at $187.
The outlook is mixed; strong analyst support and recent strategic moves like the spin-off suggest long-term growth potential, but near-term risks include integration challenges, a high P/E ratio of 67.87, and a projected decline in net profit margin for 2026. Investors should weigh solid fundamentals against current technical weakness and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
